desoxycorticosterone has been researched along with arachidonic acid in 10 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 3 (30.00) | 18.7374 |
1990's | 5 (50.00) | 18.2507 |
2000's | 2 (20.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
de Alaniz, MJ; Marra, CA | 2 |
Ferreri, NR; McGiff, JC; Schwartzmann, M | 1 |
Carretero, O; Lockette, W; Otsuka, Y | 1 |
Hall, JL; Lamb, FS; Mecca, TE; Webb, RC | 1 |
Kanagy, NL; Mecca, TE; Webb, RC | 1 |
Conetta, J; McAward, K; McGiff, JC; Oyekan, AO; Rosenfeld, L | 1 |
Cordellini, S | 1 |
Erdmann, B; Gross, V; Honeck, H; Kärgel, E; Luft, FC; Milia, AF; Neunaber, R; Schneider, W; Schunck, WH | 1 |
Hoagland, KM; Ito, O; Ito, S; Omata, K; Roman, RJ | 1 |
1 review(s) available for desoxycorticosterone and arachidonic acid
Article | Year |
---|---|
Renal prostaglandins and hypertension.
Topics: 6-Ketoprostaglandin F1 alpha; Animals; Aprotinin; Arachidonic Acid; Arachidonic Acids; Desoxycorticosterone; Dinoprostone; Epoprostenol; Humans; Hypertension; Kallikreins; Kidney; Kinins; Models, Biological; Natriuresis; Nephrons; Prostaglandins; Prostaglandins E; Renin; Urination | 1985 |
9 other study(ies) available for desoxycorticosterone and arachidonic acid
Article | Year |
---|---|
Glucocorticoid and mineralocorticoid hormones depress liver delta 5 desaturase activity through different mechanisms.
Topics: 8,11,14-Eicosatrienoic Acid; Aldosterone; Animals; Arachidonic Acid; Delta-5 Fatty Acid Desaturase; Desoxycorticosterone; Fatty Acid Desaturases; Female; Liver Neoplasms, Experimental; Microsomes, Liver; Rats; Rats, Wistar; Trypsin | 1992 |
Inhibition of arachidonate biosynthesis in hepatoma tissue culture cells by 11-deoxycorticosterone-induced factor.
Topics: 8,11,14-Eicosatrienoic Acid; Animals; Arachidonic Acid; Arachidonic Acids; Cytosol; Desoxycorticosterone; Fatty Acid Desaturases; Fatty Acids; Liver Neoplasms, Experimental; Microsomes, Liver; Rats; Rats, Inbred Strains | 1991 |
The loss of endothelium-dependent vascular relaxation in hypertension.
Topics: Acetylcholine; Animals; Aorta; Arachidonic Acid; Arachidonic Acids; Calcimycin; Desoxycorticosterone; Hypertension; In Vitro Techniques; Indomethacin; Male; Nitric Oxide; Rats; Rats, Inbred Strains; Vasodilation; Vasodilator Agents | 1986 |
Cerebral intraventricular 6-hydroxydopamine prevents vascular changes in the mineralocorticoid hypertensive rat.
Topics: Animals; Arachidonic Acid; Arachidonic Acids; Blood Pressure; Cerebral Ventricles; Desoxycorticosterone; Hydroxydopamines; Hypertension; Muscle, Smooth, Vascular; Ouabain; Oxidopamine; Rats; Rats, Inbred Strains; Vasoconstriction | 1985 |
Arachidonate metabolites and serotonin contraction of femoral arteries from DOCA-salt hypertensive rats.
Topics: Aluminum Compounds; Animals; Arachidonic Acid; Cyclooxygenase Inhibitors; Desoxycorticosterone; Drug Evaluation, Preclinical; Femoral Artery; Fluorides; Hypertension; Logistic Models; Male; Phospholipases A; Potassium Chloride; Prostaglandin-Endoperoxide Synthases; Rats; Rats, Sprague-Dawley; Serotonin; Sodium Chloride; Vasoconstrictor Agents | 1996 |
Endothelin-1 and CYP450 arachidonate metabolites interact to promote tissue injury in DOCA-salt hypertension.
Topics: Animals; Arachidonic Acid; Blood Pressure; Body Weight; Cytochrome P-450 Enzyme System; Desoxycorticosterone; Endothelin-1; Hydroxyeicosatetraenoic Acids; Hypertension; Kidney; Male; Myocardium; Organ Size; Proteinuria; Rats; Rats, Sprague-Dawley; Sodium Chloride | 1999 |
Endothelial dysfunction in DOCA-salt hypertension: possible involvement of prostaglandin endoperoxides.
Topics: Acetylcholine; Animals; Aorta; Arachidonic Acid; Blood Pressure; Cyclooxygenase Inhibitors; Desoxycorticosterone; Dose-Response Relationship, Drug; Endothelins; Endothelium, Vascular; Hypertension; Male; Piroxicam; Prostaglandin Endoperoxides; Rats; Rats, Wistar; Vasodilation | 1999 |
Cytochrome P450-dependent renal arachidonic acid metabolism in desoxycorticosterone acetate-salt hypertensive mice.
Topics: Animals; Arachidonic Acid; Bezafibrate; Chromatography, High Pressure Liquid; Cytochrome P-450 CYP4A; Cytochrome P-450 Enzyme System; Desoxycorticosterone; Hydroxyeicosatetraenoic Acids; Hydroxylation; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypertension; Hypolipidemic Agents; In Situ Hybridization; Kidney; Lovastatin; Male; Mice; Mice, Inbred Strains; Microsomes; Mixed Function Oxygenases; NADP; Nephrectomy; RNA, Messenger; Sodium Chloride | 2000 |
Effects of converting enzyme inhibitors on renal P-450 metabolism of arachidonic acid.
Topics: 8,11,14-Eicosatrienoic Acid; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Arachidonic Acid; Benzimidazoles; Biphenyl Compounds; Bradykinin; Bradykinin Receptor Antagonists; Captopril; Cytochrome P-450 CYP4A; Cytochrome P-450 Enzyme System; Desoxycorticosterone; Enalapril; Enzyme Inhibitors; Hydroxyeicosatetraenoic Acids; Kidney; Kidney Cortex; Kidney Medulla; Male; Microsomes; Mixed Function Oxygenases; NADPH-Ferrihemoprotein Reductase; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Rats; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Spironolactone; Tetrazoles | 2001 |